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7RESEARCH ARTICLE Open AccessIncreased spread and replication efficiency
of Listeria monocytogenes in organotypic
brain-slices is related to multilocus variable
number of tandem repeat analysis (MLVA)
complex
Claudia Guldimann1,2, Michelle Bärtschi1, Joachim Frey3, Andreas Zurbriggen1, Torsten Seuberlich1
and Anna Oevermann1*Abstract
Background: Listeria (L.) monocytogenes causes fatal infections in many species including ruminants and humans.
In ruminants, rhombencephalitis is the most prevalent form of listeriosis. Using multilocus variable number tandem
repeat analysis (MLVA) we recently showed that L. monocytogenes isolates from ruminant rhombencephalitis cases
are distributed over three genetic complexes (designated A, B and C). However, the majority of rhombencephalitis
strains and virtually all those isolated from cattle cluster in MLVA complex A, indicating that strains of this complex
may have increased neurotropism and neurovirulence. The aim of this study was to investigate whether ruminant
rhombencephalitis strains have an increased ability to propagate in the bovine hippocampal brain-slice model and
can be discriminated from strains of other sources. For this study, forty-seven strains were selected and assayed
on brain-slice cultures, a bovine macrophage cell line (BoMac) and a human colorectal adenocarcinoma cell line
(Caco-2). They were isolated from ruminant rhombencephalitis cases (n = 21) and other sources including the
environment, food, human neurolisteriosis cases and ruminant/human non-encephalitic infection cases (n = 26).
Results: All but one L. monocytogenes strain replicated in brain slices, irrespectively of the source of the isolate or
MLVA complex. The replication of strains from MLVA complex A was increased in hippocampal brain-slice cultures
compared to complex C. Immunofluorescence revealed that microglia are the main target cells for L. monocytogenes and
that strains from MLVA complex A caused larger infection foci than strains from MLVA complex C. Additionally, they
caused larger plaques in BoMac cells, but not CaCo-2 cells.
Conclusions: Our brain slice model data shows that all L. monocytogenes strains should be considered potentially
neurovirulent. Secondly, encephalitis strains cannot be conclusively discriminated from non-encephalitis strains with
the bovine organotypic brain slice model. The data indicates that MLVA complex A strains are particularly adept at
establishing encephalitis possibly by virtue of their higher resistance to antibacterial defense mechanisms in microglia
cells, the main target of L. monocytogenes.
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The Gram + bacterium Listeria (L.) monocytogenes is an
opportunistic food-borne pathogen with considerable
impact on human and livestock health and food safety.
It causes listeriosis [1,2], which may manifest in distinct
clinical forms including febrile gastroenteritis, abortions,
septicemia, and neurolisteriosis [2,3] and is associated
with high mortality [4,5]. In humans, L. monocytogenes
is commonly isolated in the context of meningitis [6],
and neurolisteriosis is responsible for high fatality rates
and chronic sequelae [7–10]. In farmed ruminants,
neurolisteriosis is amongst the most common causes of
central nervous system (CNS) disorders and characteris-
tically presents as encephalitis, which targets the brain-
stem (rhombencephalitis) and is often deadly [11–14].
Clinical observations in livestock may indicate differ-
ences in organ tropism between L. monocytogenes
strains. Different clinical forms of listeriosis rarely over-
lap in the same ruminant herd or in the same animal
during an outbreak [15,16]. Rhombencephalitis generally
occurs without involvement of other organs and without
inducing abortion in pregnant ruminants [17–19].
The ubiquitous nature of L. monocytogenes as a sapro-
phytic soil inhabitant constitutes a challenge for surveil-
lance and effective disease control [20]. L. monocytogenes
is divided into four phylogenetic lineages [21] as deter-
mined by various genotypic and phenotypic subtyping
tools [22–27] and may differ in virulence and the potential
to cause epidemic outbreaks [28–33]. For instance, of the
two major phylogenetic lineages I and II, which are associ-
ated with human and animal infections, lineage I is over-
represented in clinical isolates [21,22,28,31]. In contrast,
lineage II strains are more commonly isolated from food
and the environment. The two minor lineages III and IV
are rarely isolated and are associated with ruminant infec-
tions [21]. From the 13 known serotypes, serotype 4b (be-
longing to lineage I) is associated with most of the severe
clinical cases and the majority of outbreaks [34,35]. None-
theless, available subtyping methods cannot predict the
virulence of a given isolate, and the propensity of certain
subtypes to cause sporadic illness, epidemic outbreaks or
specific clinical syndromes (e.g. neurolisteriosis) remains
poorly understood [36,37].
There have been few systematic investigations of the
genetic diversity of L. monocytogenes strains isolated
from ruminants [31,38–40]. Using multilocus variable
number tandem repeat analysis (MLVA) of 183 isolates,
we could show that ruminant rhombencephalitis strains
are found predominantly in MLVA complex A and also
B, belonging to lineage I, and to a lesser extent to com-
plex C of lineage II [31]. Nearly all rhombencephalitis
strains from cattle cluster in MLVA complex A indicat-
ing that strains of this genetic complex may have
increased neurotropism and neurovirulence [31]. Thisobservation is in line with studies showing that lineage I
strains are overrepresented in rhombencephalitis, whereas
lineage II strains are equally associated with rhombence-
phalitis, septicemia and fetal infections [38,39].
The lack of a relevant model hinders experimental
determination of neurovirulent potential and neuroviru-
lence mechanisms of L. monocytogenes strains and means
that neurovirulence can at present only be defined using
data from neurolisteriosis cases [41]. In a previous study,
we developed a bovine organotypic hippocampal brain-slice
model, which is susceptible to L. monocytogenes [42]. The
aim of the present study was to investigate if ruminant
rhombencephalitis strains can be discriminated from non-
encephalitic strains using the in vitro CNS model. To this
end, bovine hippocampal slices were infected with a panel
of 47 selected L. monocytogenes strains from various
clinical, environmental and food sources. Replication and
spread of strains within brain-slice cultures were analyzed
by determination of CFU’s and size of infection foci. These
results were correlated with the source of the isolate and
MLVA–complex of the respective strains and compared to
plaque test results in two cell lines.
Results
Infection of organotypic brain-slice cultures with L.
monocytogenes strains
We analyzed replication and capacity to spread in organo-
typic hippocampal brain-slice cultures of 21 L. monocyto-
genes strains isolated from ruminant rhombencephalitis
cases and 26 strains of ruminant non-encephalitic cases
(abortion, mastitis, gastroenteritis), human clinical infec-
tions or food/environment (Additional file 1). All but one
(bovine abortion, O/D1387/06) replicated in the brain slices
(Fig. 1a) and established at least one visible focus of infec-
tion at 48 h post inoculation (Fig. 2a). Typically, values
between 105 and 107 CFU were recovered from the
brain-slices at 48 h post infection, which corresponds to a
103–105 times increase over the incubation period. Recov-
ered CFU numbers were significantly higher in brain-slices
infected with L. monocytogenes strains from MLVA com-
plex A than with strains from MLVA complex C (Fig. 1b, p
< 0.001). The difference between MLVA complexes was also
apparent with encephalitis strains, although as a statistically
non-significant tendency (p = 0.055, Fig. 1c). Additionally,
strains from complex A spread over a significantly larger
area than strains from complex C (Fig. 3a and b, p = 0.03).
No differences in CFU counts were detected when compar-
ing strains by host species or source except between human
strains isolated from cerebrospinal fluid (CSF) and environ-
mental strains (Fig. 1d and Fig. 4a). Human CSF strains
spread farther than strains isolated from small ruminants
(Fig. 3c) and from the environment (Fig. 4b).
In agreement with our previous study [42], immuno-
fluorescence with L. monocytogenes antibodies and cell
ab c*
all strains ruminant encephalitis strains only
d
all strains
Fig. 1 Replication of L. monocytogenes strains in brain-slices. Results are shown relative to the internal control strain L104. a Aligned dot plot of
the relative CFU counts of the individual strains. Red: complex A; green: complex C; blue: complex B. The horizontal line indicates the mean.
b Box plot comparing relative CFU counts between complex A and C strains. CFU counts are significantly higher in brain-slices infected with
complex A strains, * = p < 0.05. c Box plot comparing relative CFU counts between complex A and C strains isolated from ruminant
rhombencephalitis. d Box plot comparing relative CFU counts according to host species. Whiskers represent maxima and minima. The
horizontal line represents the median, + is the mean
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located in the cytoplasm of microglia, irrespective of the
strain (Fig. 2b). Only a few bacteria were associated with
neurofilaments or astrocytes (data not shown).
Plaque forming assays in cell lines
To assess whether the results obtained in the brain-slice
infection assay are tissue specific, we performed plaque
forming assays [43,44] in two cell lines: BoMac (bovine
macrophages) and CaCo-2 (human colorectal adenocar-
cinoma cell line). In parallel to the results in brain-slices,
all strains except O/D1387/06 caused plaques in the
BoMac cell line (Fig. 5a), and strains from MLVA com-
plex A caused significantly larger plaques than strains
from complex C (Fig. 5b). In contrast, plaque assays
in CaCo-2 cells demonstrated no correlation betweenplaque size and MLVA-complex (Fig. 5e). Intriguingly,
strain O/D1387/06 caused plaques half the size of the
reference strain in this cell line, although it made no pla-
ques in BoMac cells (Fig. 5d). Also, the mean absolute
plaque size of L. monocytogenes strains was significantly
larger in CaCo-2 cells than in BoMac cells (1.3 vs
0.9 mm, p < 0.001). In the Caco-2 cell line (Fig. 5f ), but
not in the BoMac cell line (Fig. 5c), human clinical
strains produced larger plaques than strains isolated
from small ruminants.
Discussion
Given the ubiquitous presence of L. monocytogenes in
the environment, discrimination of neurovirulent sub-
types would be highly desirable for surveillance purposes
and effective disease control, especially with regard to
ab
Fig. 2 Immunofluorescence stained confocal images of bacteria in infected brain-slices. a Delineation of an infection focus (yellow line). L. monocytogenes
are stained in red. The surface area covered by L. monocytogenes was drawn and calculated using the Fluoview software (Olympus FV10-ASW Version
03.01.01.09). Magnification 20×. b Representative double-immunofluorescence of a L. monocytogenes infected brain-slice. The vast majority of bacteria are
found within microglia. Left: Microglia are stained with CD68 in green. Center: L. monocytogenes in red. Right: Overlay (bar = 40 μm)
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persistent neurologic deficits associated with neurolister-
iosis [10,41]. In our study, infection assays with L. mono-
cytogenes strains from various sources and MLVA
complexes showed that all L. monocytogenes strains ex-
cept one are able to replicate and spread in bovine
brain-slices and that discrimination between rhomben-
cephalitis and non-encephalitic strains is not possible in
this system. Hence, based on our results we suggest that
all L. monocytogenes strains should be regarded as po-
tentially neurovirulent, independent of their genotype
and source of isolation. Brain-slices have the inherent
drawback that they only model the intracerebral phase
of L. monocytogenes infection and can not mimic invasion
barriers (i.e. the blood–brain barrier in hematogenous in-
fection or the cranial nerve in rhombencephalitis). Hence,
we cannot exclude that encephalitogenic strains diverge
from other L. monocytogenes strains due to their efficiency
of brain invasion.
MLVA complex A strains (lineage I) showed a higher
replication and spread farther in brain-slices than strains
from complex C, indicating that they are better adapted
to establish encephalitis. This observation is in accord-
ance with the higher prevalence of lineage I strains in
clinical infections and in particular ruminant rhomben-
cephalitis compared to lineage II strains [21,22,31].
Analysis of strains according to their source did not
identify significant differences in replication and spread
in brain-slices except between human and environmen-
tal or small ruminant isolates. However, theseobservations are likely to be related to the MLVA com-
plex of the strains. All human CSF strains belonged to
MLVA complexes A and B (lineage I), whereas all envir-
onmental and the majority of small ruminant strains
belonged to complex C (lineage II). Microglia, the innate
immune cells and resident macrophages of the CNS
[46], were the main target cells for all L. monocytogenes
strains investigated in hippocampal brain slices. The repli-
cation of L. monocytogenes within microglia indicates that
these may paradoxically act as a replication niche for L.
monocytogenes during encephalitis. In this aspect, our
model is consistent with the natural disease, where most
bacteria are found within phagocytes of microabscesses
[11].
MLVA complex A strains form larger plaques in the
bovine macrophage cell line (BoMac) than complex C
strains. Interestingly, this difference was not apparent in
CaCo-2 cells, where plaques were generally larger than
in BoMac cells, indicating a particularly high susceptibil-
ity of epithelial cells to L. monocytogenes, which does not
allow further differentiation. This notion is further sup-
ported by the fact that strain O/D1387/06, a complex C
strain that seems to be naturally attenuated, completely
failed to replicate and spread in brain-slices and to cause
plaques in BoMac cells, but caused small plaques in
CaCo-2 cells. Further analysis of this strain revealed a
novel PrfA truncation, associated with the attenuated
phenotype in vitro [47].
Our data suggests that differences in replication and
spread between L. monocytogenes strains are host cell type-
*
c *
a
b
Fig. 3 Spread of L. monocytogenes strains in brain-slices as determined by size of infection foci. Results are shown relative to the internal control
strain L104. a Aligned dot plot analysis of bacterial spread of the individual strains used in this study. Red: MLVA complex A; green: MLVA complex
C; blue: MLVA complex B. The horizontal line indicates the mean. b Box plots comparing the total size of foci between complex A and complex C
strains. Complex A strains cover a significantly larger area than complex C strains. c Box plot comparing total size of foci according to host
species. Human strains caused larger infection foci in brain-slices than strains isolated from small ruminants. Box plots: Whiskers represent
maxima and minima. The horizontal line represents the median, + is the mean, * = p < 0.05
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genes virulence from studies using various types of cell lines
may support this view [44,48–54]. Unlike CaCo-2 cells,
BoMac (derived from bovine macrophages) and microglia
share essential features including phagocytic potential and a
respiratory burst system [46]. Taken together, the more effi-
cient replication and spread of MLVA complex A vs. com-
plex C strains in microglia and macrophages suggests that
complex A strains are more resistant to mononuclear anti-
bacterial defense mechanisms. In this context, it should be
noted that listeriolysin S, a virulence factor induced by oxi-
dative stress, has been implicated in L. monocytogenes sur-
vival within phagocytes and is specifically expressed by
strains of lineage I [55].Conclusion
Our data demonstrates that all L. monocytogenes strains
should be considered potentially neurovirulent and en-
cephalitis strains cannot be conclusively discriminated
from non-encephalitis strains using the bovine organoty-
pic brain-slice model. In this CNS model, microglia cells
are the main target cells for all tested L. monocytogenes
strains, which are able to multiply in these phagocytic
cells. Correlation of MLVA data with our in vitro data
show that strains from MLVA complex A replicate and
spread better in bovine microglia and macrophages
possibly by virtue of their higher resistance to mono-
nuclear antibacterial defense mechanisms. These re-
sults support the notion that L. monocytogenes strains
**
a
b
Fig. 4 CFU counts (a) and size of infection foci (b) in organotypic
brain-slices infected with L. monocytogenes strains. Results are mapped
according to the source and associated clinical infection, respectively.
Data are presented as box plots, Whiskers represent maxima and
minima. The vertical line represents the median, + is the mean.
* = p < 0.05. CFU counts (a) and surface of bacterial spread (b) are
shown relative to the internal control strain L104
Guldimann et al. BMC Microbiology  (2015) 15:134 Page 6 of 9from MLVA complex A are highly accomplished at es-
tablishing encephalitis.
Methods
Bacterial strains
Forty-seven L. monocytogenes strains were investigated in
brain-slice cultures and cell lines (Additional file 1). The
MLVA-type of 44 strains had been obtained in a previous
study [31] and the MLVA-type of three other ruminant
isolates (JF4971, JF5052 and JF4978; Additional file 1)
were determined during this study by analysis of tandemrepeat numbers at eight loci according to Sperry et al.
[23]. A minimal spanning tree was created in the BioNu-
merics software (Version 6.6, Applied Maths Inc., Austin,
Texas, USA) in order to define the MLVA complex of the
strains [31]. Twenty-one strains isolated from ruminant
rhombencephalitis cases were selected based on the fol-
lowing criteria: 1) differences at the 8 MLVA loci and
2) similar numerical representation of the two large
MLVA complexes, to which most of the ruminant
rhombencephalitis strains belong (MLVA complex A: n
= 12; MLVA complex C: n = 9). The ruminant rhomben-
cephalitis strains were compared to a similar number of L.
monocytogenes strains from other sources (n = 26) avail-
able in our strain collection (Additional file 1). The latter
included strains from ruminant non-encephalitic cases
including gastroenteritis, mastitis and abortion (n = 7),
human clinical cases (n = 9), food and environmental
(n = 10) and mainly belonged to MLVA complex C
(n = 18). Four strains belonged to MLVA complex A, one
strain was a single locus variant associated with MLVA
complex A and three strains belonged to MLVA complex
B. Non-invasive Listeria innocua type strain CCUG15531T
(Culture Collection University of Göteborg) was used as
negative control.
Organotypic brain-slice cultures
Hippocampal brain samples from calves under 6 months
of age were obtained from the slaughterhouse. A
vibratome (Leica VT1000S) was used to cut 350 μm
brain-slices and were cultured on membrane inserts
(Vitaris, No. 3450 or 3460) as previously described [42].
Infection assays in ruminant organotypic brain-slice
cultures
Brain-slices were infected at day 7 in culture. Penicillin
and streptomycin were removed from the organotypic
brain-slice cultures 1 h prior to inoculation in the first
set of experiments and 4 days prior to inoculation in the
later experiments due to batch variation of the antibi-
otics. Medium was changed to a serum-free formula 1 h
prior to inoculation. Bacteria were plated on trypticase
soy agar (TSA), incubated at 37 °C for 15 h and subse-
quently diluted using the McFarland optical density
standard. One hundred CFU in 0.1 μl NaCl (determined
by plating on TSA plates) were focally injected into the
dentate gyrus of the hippocampus using a 0.5 μl syringe
(Hamilton, 7402 Bonaduz, Switzerland. Model 7000.5
KHOC) and a micromanipulator (made in-house).
Brain-slices were incubated with the bacteria for 3 h and
subsequently the inoculation medium was substituted
with gentamicin-containing medium (final concentration
0.01 mg/ml). All experiments were carried out at least in
triplicate and included L. innocua (negative control)
and an internal control strain (L104, from bovine
a b
d e
*
c
f
*
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oM
ac
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2
Fig. 5 Plaque sizes of L. monocytogenes strains in the BoMac and CaCo-2 cell lines. Results are shown relative to the internal control strain L104.
a The relative plaque size in BoMac-cells is shown for each strain as an aligned dot plot. Red: complex A strains; green: complex C strains; blue:
complex B strains. The horizontal line indicates the mean. b Box plots comparing plaque size in BoMac cells between complex A and complex C
strains. Plaques of complex A strains are significantly larger than those of complex C strains. The horizontal line represents the median, + is the
mean. c The host species had no influence on plaque-size in BoMac cells. d CaCo-2 cells: the relative plaque size for each strain is shown as an
aligned dot plot. Red: Complex A; green: Complex C; blue: Complex B. The horizontal line indicates the mean. e Box plots comparing plaque size
in CaCo-2 cells between complex A and complex C strains. There is no difference in plaque size between complex A and C strains. e Human
strains formed larger plaques in CaCo-2 cells than strains isolated from small ruminants. * = p < 0.05. Box plots: Whiskers represent maxima and
minima. The horizontal line represents the median, + is the mean
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For analysis of bacterial replication CFU’s were determined
48 h post infection by lysing infected brain-slices in 1 ml
PBS containing 55 μl Isolator (Wampole, Oxoid) and plat-
ing serial dilutions on TSA plates. For analysis of bacterial
spread, brain-slices were fixed in 4 % (w/v) paraformalde-
hyde at 48 h post infection. Following overnight fix-
ation, brain-slices were incubated in 18 % (w/v)
sucrose (Sigma, S0389) for 12 h, cut with a cryotome
into 4.5 μm-thick sections and stored at −20 °C until
further use. Immunofluorescence was performed using
the following primary antibodies: anti-Listeria O sero-
types 1 and 4 (polyclonal rabbit antibody, No. 223021,
Difco, Sparks, MD, USA), neurofilament (monoclonal
mouse antibody, No M0762, DAKO, Glostrup, Denmark),
GFAP (monoclonal mouse antibody, No. Ab4648, Abcam,
Cambridge UK) and CD68 (monoclonal mouse antibody,
clone EBM11, DAKO, Glostrup, Denmark). Alexa Fluor
488 and 544 were used as secondary antibodies (No.
A21428, Invitrogen, Carlsbad, CA, USA,) [42]. Nuclei were
stained with TOTO-3 (no T3604, Invitrogen, Carlsbad,
CA USA), and 10x images were acquired on an Olympus
FV1000 confocal microscope. The total area covered by
L. monocytogenes was measured on the immunofluores-
cence labeled cryosections of brain-slices using the
Olympus FV10-ASW Version 03.01.01.09 software and
expressed in μm2.Plaque assay in bovine macrophages and CaCo-2 cells
Plaque forming assays were performed according to a
previous study [31] in an immortalized bovine macrophage
cell line (BoMac, kindly provided by D. Dobbelaere, Depart-
ment of Clinical Research and Veterinary Public Health,
Vetsuisse Faculty Bern) and the human enterocyte-like
CaCo-2 cell line (ATCC No. HTB37). Both cell lines were
grown in DMEM (Gibco 61965–026) supplemented with
penicillin/streptomycin (Gibco, 15140–122, used 1:100)
and 10 % fetal calf serum (FCS) (BoMac cells) or 20 % FCS
(CaCo-2 cells), respectively. Cells were grown to confluence
in a 24-well plate overnight at 37 °C, washed with warm
PBS and inoculated with 103 CFU L. monocytogenes (MOI
0.01) in antibiotic free medium supplemented with 2 %
FCS. Following 1 h incubation the medium was removed,
cells were washed with PBS and overlaid with medium con-
taining 0.7 % agarose and 0.01 mg/ml gentamicin. The size
of five randomly chosen plaques per well were measured
72 h post infection. Experiments were carried out in dupli-
cate and the internal control strain L104 was included in all
experiments.
Statistical analysis
All results were normalized to the internal control strain
L104. Statistical analysis was performed with the Prism
Software (Version 5.03, Graph Pad Software Inc.). The
Mann–Whitney test was used to determine the p-values
Guldimann et al. BMC Microbiology  (2015) 15:134 Page 8 of 9where two groups were compared. For comparison of
multiple groups, the Kruskal-Wallis test was used with
Dunn’s multiple comparisons as post-test. As only three
strains belonged to complex B, they were excluded from
the statistical analysis comparing complexes.Additional file
Additional file 1: L. monocytogenes strains used in this study. MLVA
and serotype data have been either obtained from [31] or were
generated in this study (*). SLV Single locus variant, N/a Not applicable,
Nd Not determined, CSF Cerebrospinal fluid.
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